STAT
JUNE 16, 2025
The staff of two world-class laboratories at the Centers for Disease Control and Prevention that were slated to be closed in a round of cuts announced in April have been informed that their terminations have been canceled. The CDC’s sexually transmitted disease laboratory and its viral hepatitis laboratory were targets of layoffs initiated by the U.S.
Express Pharma
JUNE 16, 2025
Lupin has entered into a licence and supply agreement with Sino Universal Pharmaceuticals (SUP) for the commercialisation of Tiotropium Dry Powder Inhaler (DPI), 18 mcg/capsule, in the Chinese market. The product is indicated for the treatment of chronic obstructive pulmonary disease (COPD). According to the terms of the agreement, SUP will be responsible for securing regulatory approvals required to market Tiotropium DPI in China.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
STAT
JUNE 16, 2025
NEW YORK — All 17 experts recently dismissed from a government vaccine advisory panel published an essay Monday decrying “destabilizing decisions” made by U.S. Health Secretary Robert F. Kennedy Jr. that could lead to more preventable disease spread. Kennedy last week announced he would “retire” the entire panel that guides U.S. vaccine policy.
World Pharma News
JUNE 16, 2025
Researchers at VCU Massey Comprehensive Cancer Center have developed a novel algorithm that could provide a revolutionary tool for determining the best options for patients - both in the treatment of cancer and in the prescription of medicines. As recently published in Nature Communications, Jinze Liu, Ph.D., and Kevin Byrd, D.D.S., Ph.D., created Threshold-based Assignment of Cell Types from Multiplexed Imaging Data (TACIT), which assigns cell identities based on cell-marker expression profiles
Speaker: Jennifer Hill
Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.
STAT
JUNE 16, 2025
A central theme in Humana’s plan for boosting Medicare Advantage profitability in the future is a strategy its peers have relied on for over a decade: coaxing members in for their annual wellness visits. The Medicare Advantage business has come under fire in recent months for its outsized impact on the federal budget, and the potentially billions of dollars that could come from limiting insurers’ tactics for maximizing their government payments.
Drug Patent Watch
JUNE 16, 2025
"The Patent Cliff: A Looming Tsunami for Big Pharma As the pharmaceutical industry stands at the precipice of a seismic shift, one question looms large: what happens when the patents expire? A new analysis from Drug Patent Watch reveals the hidden timeline behind generic drug entry, and the market dynamics that will be reshaped in its wake.
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
EMCrit Project
JUNE 16, 2025
Home EMCrit PulmCrit IBCC ODR About About EMCrit PulmCrit – The Full Story EMCrit FAQ Subscribe to the Newsletter Contact Join Why Should I Become a Member? Questions Before Joining (FAQ) Join Now! EMCrit Project Online Medical Education on Emergency Department (ED) Critical Care, Trauma, and Resuscitation EMCrit Archives EDICUs Show Types ▿ Foundational Stabilization (FoundStab) Project RACC-Lit CV-EMCrit Mind of the Resuscitationist Procedures Outside Shows You are here: Home / EMCrit / 1:1 Nu
STAT
JUNE 16, 2025
In the face of rising national infertility and economic uncertainty, the institution of family is more important than ever. With 1 in 6 globally experiencing infertility , the current administration’s presidential order to make in vitro fertilization more affordable was a welcome development. It may be light on action, but it shows our government recognizes that building families strengthens the foundation of society, safeguards tomorrow, and ensures long-term stability.
Express Pharma
JUNE 16, 2025
Merck’s Enflonsia (clesrovimab) has received FDA approval for the prevention of respiratory syncytial virus (RSV) lower respiratory tract disease (LRTD) in newborns and infants born during or entering their first RSV season. Enflonsia, is a long-acting monoclonal antibody (mAb) that can provide protection through a typical 5-month RSV season with a 105mg dose, regardless of weight.
STAT
JUNE 16, 2025
Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. Good morning. Later this week, I’ll be going on my first long-distance bike trip. Send tips — on cycling, snacking, or news — to theresa.gaffney@statnews.com.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Pharma Marketing Network
JUNE 16, 2025
In an industry defined by compliance, complexity, and fierce competition, connecting with healthcare professionals (HCPs) effectively is both an art and a science. That’s where HCP targeting comes in—an evolving pillar of pharmaceutical marketing that blends precision, personalization, and performance. Pharma brands know that not all doctors are equal when it comes to prescribing behavior, influence, or engagement preferences.
STAT
JUNE 16, 2025
This is the online version of our BIO 2025 newsletter. Get more BIO updates directly to your inbox by signing up here , and sign up for our morning biotech news roundup newsletter here. Hello everyone! Allison DeAngelis here, coming to you from Boston’s Convention and Exhibition Center, where I just did laps around the BIO exhibition hall in search of the special edition pin for this year’s conference.
Pharma Marketing Network
JUNE 16, 2025
Pharmaceutical advertising has always been complex. From regulatory hurdles to evolving consumer expectations, the space demands constant adaptation. As we move deeper into 2025, brands are navigating a rapidly transforming landscape. Pharmaceutical advertising is no longer just about branded TV spots or full-page journal ads—it’s about omnichannel engagement, data-driven strategies, and personalized experiences.
Pharmafile
JUNE 16, 2025
Swiss biopharma, Roche, has announced its decision to proceed with phase 3 trials of prasinezumab, an investigational therapy for Parkinson’s disease. This decision is influenced by positive data from the phase 2b PADOVA study, ongoing open-label extensions (OLEs) of PADOVA as well as phase 2 PASADENA studies. Multiple endpoints from the PADOVA and OLE studies […] The post Roche advances treatment for Parkinson’s disease appeared first on Pharmafile.
Advertisement
Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.
pharmacy mentor
JUNE 16, 2025
The online pharmacy sector is booming — and it’s changing the way people access healthcare. As consumers demand faster, more convenient ways to receive their prescriptions and health advice, ePharmacies are stepping in to meet that need with innovative digital solutions. With global and regional markets showing impressive growth rates, it’s clear that online pharmacies are not just a trend — they are shaping the future of healthcare delivery.
pharmaphorum
JUNE 16, 2025
Millions of people in the UK will be given the opportunity to take part in clinical trials via the NHS App
Pharmafile
JUNE 16, 2025
Shilpa Biocare, a wholly owned subsidiary of Shilpa Medicare, has signed a commercial supply agreement with Finland-based Orion Corporation for its recombinant human albumin. The agreement, announced ahead of the BIO International Convention in Boston, US, grants Orion exclusive rights to distribute, market and sell the product across Europe. Recombinant human Aabumin is a synthetic […] The post Shilpa Medicare and Orion partner, expanding into European market appeared first on Pharmafile.
PharmaTech
JUNE 16, 2025
PharmTech Group spoke with Andy Burns, vice-president of MDI Business Development at Kindeva, ahead of BIO 2025 to find out what’s new in pulmonary drug delivery.
Speaker: Joe Sharpe and James Carlson
Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.
Drug Channels
JUNE 16, 2025
This week, I’m rerunning some popular posts while I prepare for Friday’s live video webinar: What’s Next for Retail Pharmacy: Data, Debate, and Disruption. I’ll be joined by special guest Antonio Ciaccia, CEO of 46brooklyn Research, and President of 3 Axis Advisors. Click here to see the original post from March 2025. Next week, Drug Channels Institute (DCI) will release our 2025 Economic Report on U.S.
Pharmaceutical Commerce
JUNE 16, 2025
Many uninsured and underinsured individuals remain unaware of vital financial assistance programs for prescription costs, highlighting a critical need for increased awareness and resources.
PhRMA
JUNE 16, 2025
The United States leads the world in the research and development, manufacturing and access of innovative medicines. Today, more than half of global biopharmaceutical research and development happens in the United States alone. That’s not by accident: America’s innovation ecosystem is the best in the world, thanks to a policy environment that incentivizes innovation and rewards progress, and it supports workers, the economy and our patients.
Pharmaceutical Commerce
JUNE 16, 2025
In the third part of her Pharma Commerce video interview, Kirsten Newquist, Identiv’s CEO, shares the ways in which regulations, including DSCSA, are impacting the adoption of smarter packaging technologies across the industry.
Advertisement
Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.
The Pharmacist
JUNE 16, 2025
The Royal Pharmaceutical Society (RPS) has appointed a new director for England who is ‘passionate about delivering high quality patient care and advocating on behalf of the profession.’ Amandeep Doll, a specialist medical pharmacist at Nottingham University Hospital Trust, and head of engagement at the RPS, will take up the new role in August this […] The post RPS new director for England will build a ‘vibrant future’ for pharmacy appeared first on The Pharmacist.
Pharma Times
JUNE 16, 2025
Subscribe Advertise About us Follow Follow Follow Follow GO Magazine PharmaTimes Magazine Archive Web Exclusives News Competitions Appointments Business Insights Webinars Thought Leadership Jobs Investigational treatment shows promise for aggressive multiple myeloma by John Pinching | 16th Jun 2025 | News Results suggest bispecific antibody combination could improve outcomes A new investigational treatment has shown strong and lasting responses in multiple myeloma patients with extramedullary di
European Pharmaceutical Review
JUNE 16, 2025
UCB is planning a major manufacturing investment that is expected to provide a significant economic impact of approximately $5 billion in the US. The biopharmaceutical company intends to expand its biologics manufacturing capacity with a new facility in the country. This supports future medicine delivery and a more resilient and sustainable supply chain, according to UCB.
Big Molecule Watch
JUNE 16, 2025
On June 9, 2025, biosimilar manufacturers Samsung Bioepis and Alvotech announced separate deals to expand their respective offerings in Japan and Europe. Samsung Bioepis announced a licensing, development, and commercialization agreement with NIPRO Corporation for multiple biosimilar candidates in Japan. One of these candidates is SB17, a biosimilar of Janssen’s STELARA (ustekinumab).
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
pharmaphorum
JUNE 16, 2025
At BIO 2025 in Boston today, pharma and biotech leaders discussed the current state of AI in the drug development life cycle.
Pharmaceutical Business Review
JUNE 16, 2025
This collaboration is expected to strengthen the country’s role as an international hub for drug discovery. This new support is part of several programmes under the Medical Innovation Support Office (MEDISO) of the Ministry of Health, Labour and Welfare, aimed at bridging the gap between Japan’s life sciences technologies and their real-world implementation.
Pharmaceutical Technology
JUNE 16, 2025
NHS England now offers the "Trojan horse" therapy, belantamab mafodotin (Blenrep) for patients with multiple myeloma.
Pharmaceutical Commerce
JUNE 16, 2025
The biopharma company—whose US headquarters is in Atlanta—will be building a new biologics manufacturing facility in a city to be named at a later date.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Expert insights. Personalized for you.
362 
Let's personalize your content